Affordability of Medicines a Top Priority for EHA: Toward a Fair Pricing Model for Innovative Medicines

被引：2
|
作者：
Hagenbeek, Anton [2 ]
Engert, Andreas [3 ]
Kapitein, Peter [2 ,3 ]
Doeswijk, Robin [1 ]
机构：
[1] EHA European Affairs, The Hague, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Amsterdam, Netherlands
[3] Univ Hosp Cologne, Cologne, Germany
来源：
HEMASPHERE | 2017年 / 1卷 / 01期
关键词：
D O I：
10.1097/HS9.0000000000000012
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 45 条
  • [21] PRICING, AVAILABILITY, AFFORDABILITY, PRICE COMPONENTS OF ESSENTIAL ANTICANCER MEDICINES IN ADDIS ABABA, ETHIOPIA
    Tadesse, N.
    Fang, Y.
    VALUE IN HEALTH, 2018, 21 : S53 - S53
  • [22] Availability, pricing, and affordability of antithrombotic medicines in Addis Ababa, Ethiopia: implications for health policy
    Birhanu, Selam
    Tamiru, Melaku Tileku
    Kedir, Hanan Muzeyin
    Tadesse, Tamrat Assefa
    JOURNAL OF PHARMACEUTICAL HEALTH CARE AND SCIENCES, 2025, 11 (01):
  • [23] Ensuring access to medicines at a fair price? Innovative contracting experiences in France
    Alaoui, I.
    Izambert, C.
    Toullier, A.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2020, 30 : V31 - V31
  • [24] "DIRECT ACCESS" EXPERIMENT IN FRANCE: POTENTIAL IMPACT ON THE PRICING OF INNOVATIVE MEDICINES
    Kloc, K.
    Kowalska, M.
    VALUE IN HEALTH, 2023, 26 (12) : S291 - S291
  • [25] Availability, pricing and affordability of essential medicines in Eastern Ethiopia: a comprehensive analysis using WHO/HAI methodology
    Sisay, Mekonnen
    Amare, Firehiwot
    Hagos, Bisrat
    Edessa, Dumessa
    JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2021, 14 (01)
  • [26] Availability, pricing and affordability of essential medicines in Eastern Ethiopia: a comprehensive analysis using WHO/HAI methodology
    Mekonnen Sisay
    Firehiwot Amare
    Bisrat Hagos
    Dumessa Edessa
    Journal of Pharmaceutical Policy and Practice, 14
  • [27] PRICING AND REIMBURSEMENT OF INNOVATIVE MEDICINES: CHALLENGES AND LESSONS FROM SOUTH-EASTERN EUROPE
    Bobinac, A.
    Banovic, I
    Atanasijevic, D.
    Harsanyi, A.
    Hristova, K.
    Mardare, I
    Vila, M.
    Kamusheva, M.
    Dimitrova, M.
    Furst, J.
    Strbad, T.
    Voncina, L.
    VALUE IN HEALTH, 2021, 24 : S180 - S181
  • [28] WHAT ARE THE OPPORTUNITIES FOR FLAT PRICING OF INNOVATIVE MEDICINES ACROSS THE EU4 AND UK?
    San Segundo Gonzalez, A.
    Conceicao, R.
    Borga, P.
    Haigh, J.
    VALUE IN HEALTH, 2022, 25 (12) : S259 - S259
  • [29] REIMBURSEMENT AND PRICING OF INNOVATIVE MEDICINES: EU5 POLICIES AND IMPLICATIONS FOR MARKET ACCESS
    Nwogu, G.
    Brown, A.
    Falk, K.
    Murray, G.
    Pritchett, L.
    Wiesinger, A.
    VALUE IN HEALTH, 2015, 18 (07) : A551 - A552
  • [30] The Availability, Pricing and Affordability of Three Essential Asthma Medicines in 52 Low- and Middle-Income Countries
    Zaheer-Ud-Din Babar
    Charon Lessing
    Cécile Mace
    Karen Bissell
    PharmacoEconomics, 2013, 31 : 1063 - 1082
12345